A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC)Xingsheng Hu, Yan Sun, Meina Wu et al.|Lung Cancer|2014Cited by 51
Outcomes of the rehabilitative procedure for patients with pulmonary atresia, ventricular septal defect and hypoplastic pulmonary arteries beyond the infant periodYi Zhang, Shiqi Li, Kun‐Qi Yang et al.|European Journal of Cardio-Thoracic Surgery|2014Cited by 29
Real‐world data on EGFR/ALK gene status and first‐line targeted therapy rate in newly diagnosed advanced non‐small cell lung cancer patients in Northern China: A prospective observational studyHongge Liang, Mengzhao Wang, Xia Song et al.|Thoracic Cancer|2019Cited by 26
Safety and efficacy results of a phase IV, open-label, multicenter, safety-monitoring study of icotinib in treating advanced non-small cell lung cancer (NSCLC): ISAFE study.Fenlai Tan, Yan Sun, Aiqin Gu et al.|Journal of Clinical Oncology|2013Cited by 5
Investigation of the phosphatidylinositol 3-kinase pathway in B cellsKewei Ma|cIRcle (University of British Columbia)|2009Cited by 0